Cargando…
Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?
BACKGROUND: With the introduction of several drugs for the therapy of transthyretin-related amyloidosis (ATTR) which slow down the disease, early detection of polyneuropathy (PNP) is becoming increasingly of interest. [99mTc]-3,3-Diphosphono-1,2-Propanodicarboxylic Acid (DPD) bone scintigraphy, whic...
Autores principales: | Wollenweber, Tim, Kretschmer-Chott, Elisabeth, Wurm, Raphael, Rasul, Sazan, Kulterer, Oana, Rettl, Rene, Duca, Franz, Bonderman, Diana, Sühs, Kurt-Wolfram, Hacker, Marcus, Traub-Weidinger, Tatjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984356/ https://www.ncbi.nlm.nih.gov/pubmed/35817943 http://dx.doi.org/10.1007/s12350-022-02986-7 |
Ejemplares similares
-
Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters
por: Wollenweber, Tim, et al.
Publicado: (2022) -
In Vivo Quantification of Myocardial Amyloid Deposits in Patients with Suspected Transthyretin-Related Amyloidosis (ATTR)
por: Wollenweber, Tim, et al.
Publicado: (2020) -
Quantitative SPECT/CT parameters of myocardial (99m)Technetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
por: Ben-Haim, Simona, et al.
Publicado: (2021) -
An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
por: Schatka, Imke, et al.
Publicado: (2021) -
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy
por: Rettl, René, et al.
Publicado: (2023)